IR-Med Inc. (OTCQBIRME) Revenue and Competitors
Estimated Revenue & Valuation
- IR-Med Inc. (OTCQBIRME)'s estimated annual revenue is currently $2.7M per year.
- IR-Med Inc. (OTCQBIRME)'s estimated revenue per employee is $224,000
Employee Data
- IR-Med Inc. (OTCQBIRME) has 12 Employees.
- IR-Med Inc. (OTCQBIRME) grew their employee count by -20% last year.
IR-Med Inc. (OTCQBIRME)'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Co-Founder, CSO and Director | Reveal Email/Phone |
3 | CFO | Reveal Email/Phone |
4 | Head Software & AI | Reveal Email/Phone |
IR-Med Inc. (OTCQBIRME) Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.9M | 13 | 30% | N/A | N/A |
#2 | $1.1M | 6 | 200% | N/A | N/A |
#3 | $9.2M | 30 | 3% | N/A | N/A |
#4 | $3.5M | 15 | 7% | $14M | N/A |
#5 | $4.5M | 17 | 0% | $53M | N/A |
#6 | $2.7M | 12 | -20% | N/A | N/A |
#7 | $2.7M | 12 | 20% | N/A | N/A |
#8 | $5.2M | 19 | 6% | $15M | N/A |
#9 | $7.9M | 26 | 8% | $9.7M | N/A |
What Is IR-Med Inc. (OTCQBIRME)?
IR-MED Inc. is developing a cutting-edge infrared spectroscopy and AI analysis technology platform as a basis for point-of-care decision support devices. The infrared spectroscopy technology allows harmless and non-invasive gathering of bio-information from patient blood and tissue. Bioinformation is then analyzed using the company’s AI process to provide healthcare professionals with decision support in assessment of various disease conditions.\n\nPressureSafe, the company’s first product based on this platform, is a handheld device designed to revolutionize assessment of pressure injuries (PI) affecting skin and underlying tissue. Pressure Injury in the US alone accounts for $26.8B in healthcare spending and results in 60,000 deaths annually. PressureSafe is expected to contributes to assessment of pressure injuries before skin breakage , regardless of patient skin tone. This will drive equitable healthcare and help reduce the toll and cost of PI.\n\nIR-MED holds patents protecting its innovation in noninvasive tissue assessment. \n \n\n \n \n Show more\n \n\n \n\n\n \n \n Show less
keywords:N/A
N/A
Total Funding
12
Number of Employees
$2.7M
Revenue (est)
-20%
Employee Growth %
N/A
Valuation
N/A
Accelerator